Ion Beam Applications SA IBA (GB:0GZK) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Ion Beam Applications SA (IBA) showcased robust growth in its third quarter of 2024, with a significant increase in equipment order intake reaching EUR 215 million and a strong order book valued at EUR 1.4 billion. The company also highlighted a successful EUR 93 million funding round for its joint venture, PanTera, to advance the production of actinium 225, alongside notable progress in its Proton Therapy and Other Accelerators businesses. With a positive financial outlook and strategic investments, IBA remains confident in its performance for the year.
For further insights into GB:0GZK stock, check out TipRanks’ Stock Analysis page.